The association between IR expression and a progressed disease at the time of diagnosis might additionally root in interactions between the IR and other tyrosine kinase receptors—such as observed in gastric cancer with the HER2 receptor [7]—and has to be closely looked at. This evidence concerns the gene NTRK1 and gastric cancer.